PharmiWeb55m
Medios AG reports record quarter Q3 2024 with significant increase in earnings and margins (news with additional features)
Month figures/Quarterly / Interim StatementMedios AG reports record quarter Q3 2024 with significant increase in earnings and margins (news with additional features)12.11.2024 / 08:41 CET/CESTThe ...
PharmiWeb2h
AEVIS VICTORIA SA – Continued organic growth in the third quarter of 2024
AEVIS VICTORIA SA (AEVIS) achieved total revenues of CHF 761.0 million as at 30 September 2024, an increase of 7.1% compared to CHF 710.2 million in 2023. On a comparable basis, organic revenue growth ...
PharmiWeb2h
Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites
ExpansionLonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites 12.11.2024 / 07:00 CET/CEST The expansion of bioconjugation capabilities will provide additional ...
PharmiWeb17h
The Rise of Elastography Imaging: A Multi-Billion Dollar Industry
The global elastography imaging market is experiencing significant growth, with projections indicating that the industry will ...
PharmiWeb2h
DINAMIQS opens new lab in Zurich
Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen (Switzerland), reached another milestone on ...
PharmiWeb11h
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
BOULDER, CO / ACCESSWIRE / November 11, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized ...
PharmiWeb14h
US Med-Equip Named 'Top Workplace' for 6th Year Running, Fueled by Employee Dedication to Life-Saving Mission
Leading medical equipment provider recognized for its 'people-first culture,'empowering working environment supporting hospitalsHOUSTON, TX / ACCESSWIRE / November 11, 2024 / Employees at US Med-Equip ...
PharmiWeb15h
Formycon extends Management Board contract for CEO…
Personnel/ContractFormycon extends Management Board contract for CEO Dr. Stefan Glombitza until 2027 and receives admission to trading in the Prime Standard 11.11.2024 / 17:41 CET/CESTThe issuer is ...
PharmiWeb17h
Scottish Medicines Consortium Accepts Kite CAR T-Cell Therapy for Earlier Use to Treat Aggressive Blood Cancers
Scottish Medicines Consortium Accepts Kite CAR T-Cell Therapy for Earlier Use to Treat Aggressive Blood Cancers - First SMC acceptance of any CAR T-cell therapy for lymphoma patients in the ...
PharmiWeb16h
The Tandem Meetings of ASTCT and CIBMTR Return to Hawai'i From February 12-15, 2025
ASTCT® and CIBMTR® Bring Leading Experts Together to Share Groundbreaking Advancements in Hematopoietic Cell Transplantation, Cellular Therapy and Gene Therapy. Throughout the meetings, world-class ...
PharmiWeb17h
InnoScot Health innovation drive set to inspire nurses, midwives, and AHPs to help improve NHS Scotland
New innovation drive set to inspire nurses, midwives, and AHPs to help improve NHS ScotlandFormal NHS Scotland partner InnoScot Health is launching a fresh innovation push with the aim of inspiring ...
PharmiWeb19h
First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial
Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...